Moderna (MRNA) PT Raised to $38 at BofA Securities
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $158.07 --0%
Rating Summary:
7 Buy, 21 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 5 | New: 6
Rating Summary:
7 Buy, 21 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 5 | New: 6
Join SI Premium – FREE
BofA Securities analyst Alec Stranahan raised the price target on Moderna (NASDAQ: MRNA) to $38.00 (from $34.00) while maintaining a Underperform rating.
You May Also Be Interested In
- Moderna (MRNA) spreader of 1K contracts of September 25 weekly 157.50 and 165 calls as share price up 10.5%
- Moncler SpA (MONC:IM) (MONRY) PT Lowered to EUR50 at Morgan Stanley
- Salvatore Ferragamo SpA (SFER:IM) (SFRGY) PT Lowered to EUR9 at Kepler Cheuvreux
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
